This resolution seeks to disapprove the 2025 Medicare Home Health Prospective Payment System rule, effectively nullifying its updates to payment rates and program requirements.
Andrew Clyde
Representative
GA-9
This resolution seeks to exercise congressional disapproval of a 2025 CMS rule governing Medicare home health payment rates and policy requirements. If passed, the resolution would nullify the rule, preventing it from taking legal effect.
Congress is using a specific legislative tool to hit the 'undo' button on a major set of updates for Medicare home health services. This resolution officially disapproves a rule issued by the Centers for Medicare & Medicaid Services (CMS) that was slated to overhaul payment rates and quality standards for 2025. By doing this, the government is essentially freezing the status quo. If this resolution holds, the new 89 Fed. Reg. 88354 regulations—which covered everything from how much agencies get paid to how they report their quality of care—will have no legal power, leaving the current rules of the road in place for the foreseeable future.
The most immediate impact of this move hits the wallet of the home health industry and, by extension, the patients they serve. The original CMS rule included a 'Prospective Payment System' update, which is fancy talk for how much the government pays agencies to send a nurse or therapist to your house. For a family managing a grandparent’s recovery from surgery at home, this means the financial landscape for their care providers isn't going to shift under their feet next year. While the rule aimed to adjust rates for 2025, blocking it ensures that providers won't have to scramble to adapt to new payment formulas or potential cuts that might have been tucked into the update.
This isn't just about the bottom line; it’s also about how care is measured and delivered. The blocked rule included updates to the 'Home Health Quality Reporting Program' and the 'Value-Based Purchasing' model—systems designed to reward agencies that show better patient outcomes. If you’re a patient who relies on specialized services like Home Intravenous Immune Globulin (IVIG), the rate updates for those specific supplies are also being scrapped. While some might see this as avoiding unnecessary red tape, the trade-off is that any planned improvements to quality tracking or incentives for better care are now off the table.
The real-world tension here is between stability and progress. On one hand, home health agencies—from small local businesses to large networks—get a reprieve from implementing complex new reporting requirements and payment structures during an already busy year. On the other hand, if the 2025 rule contained measures to lower costs for Medicare beneficiaries or increase the efficiency of the program, those benefits are now lost. For the average person juggling the costs of elder care, this move keeps things predictable, but it also means any potential fixes for a clunky system are being sent back to the drawing board.